GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regnum Corp (OTCPK:RGMP) » Definitions » Common Stock

Regnum (Regnum) Common Stock : $0.02 Mil (As of Mar. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Regnum Common Stock?

Regnum's quarterly common stock stayed the same from Sep. 2022 ($0.02 Mil) to Dec. 2022 ($0.02 Mil) and stayed the same from Dec. 2022 ($0.02 Mil) to Mar. 2023 ($0.02 Mil).

Regnum's annual common stock declined from Dec. 2020 ($0.02 Mil) to Dec. 2021 ($0.02 Mil) but then stayed the same from Dec. 2021 ($0.02 Mil) to Dec. 2022 ($0.02 Mil).

Regnum Common Stock Historical Data

The historical data trend for Regnum's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regnum Common Stock Chart

Regnum Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Common Stock
Get a 7-Day Free Trial 0.02 0.02 0.02 0.02 0.02

Regnum Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.02

Regnum Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Regnum (Regnum) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regnum Corp (OTCPK:RGMP) » Definitions » Common Stock
Comparable Companies
QBIO CALA PPCB RGIN RSPI RGTPQ ATRX HGEN MYMX NMTRQ OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
600 Third Avenue, 19th Floor, New York, NY, USA, 10016
Website
https://www.regnumcorp.com
Regnum Corp is focused on developing and commercializing therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a CCR5 antagonist to treat multi-drug resistant HIV infection.

Regnum (Regnum) Headlines

No Headlines